Taiwan Diabetes Registry (TDR)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 24,000
- 试验地点
- 1
- 主要终点
- Provide data on patient characteristics
研究概览
简要总结
To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease，Macrovascular Disease and Neuropathy in Patients With Diabetes.
详细描述
At the first year (2015), the patients ever enrolled into the quality control study by Taiwan Association of Diabetes Educators in 2006 and 2011 will be recruited, and their relevant clinical data will be regularly registered yearly until 2030. In addition, it is planned that type 1 diabetic patients will be enrolled, and their clinical data will be regularly recorded yearly until 2030. Also, newly diagnosed type 2 diabetic patients will be recruited, and their clinical data will be regularly entered to the diabetes web-based system yearly until 2030. We will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030. Finally, we will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of diabetes mellitus
排除标准
- •Patients who do not have diabetes mellitus
- •Participating in an interventional trial requiring informed consent
结局指标
主要结局
Provide data on patient characteristics
时间窗: Ten years
Provide data on disease management.
时间窗: Ten years
次要结局
未报告次要终点